| Description | Ravagalimab (ABBV-323), a CD40 antagonist with an EC50 of 3.7 nM, is utilized in the research of Crohn's disease [1]. |
| molecular weight | N/A |
| CAS | 2050816-56-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |
| Description | Ravagalimab (ABBV-323), a CD40 antagonist with an EC50 of 3.7 nM, is utilized in the research of Crohn's disease [1]. |
| molecular weight | N/A |
| CAS | 2050816-56-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |